BPC-157 is not approved by Health Canada or the FDA for therapeutic use
Continuing to consume gluten, however, can result in general malnutrition, the development of other autoimmune disorders, and in some cases, gastrointestinal associated cancers
Treatment of chronic inflammatory diseases and now COVID-19 appears to be complex and may resist finding a single silver bullet intervention (247) supporting the use of combination therapies (170)
Chemical modifications such as lipidation (first applied therapeutically to insulin in the 1990s), PEGylation (established as a platform technology in the early 2000s), and reversible albumin binding have transformed peptides from short-lived signaling molecules into durable therapeutics suitable for weekly or even monthly administration ( In parallel, advances in formulation science and delivery technologies have expanded the feasible routes of peptide administration
It is specifically beneficial in addressing alcoholic fatty liver, which results from excessive alcohol consumption, liver fibrosis/cirrhosis caused by alcohol abuse, and hepatitis, which is the inflammation of the liver
BPC 157 injections take effect quite quickly
.png)
